Global Gastroscopes Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Application;
Contraindications, Gastric Ulcer, and Chronic Gastritis.By Type;
Standard Gastroscopes, Transnasal Gastroscopes, Therapeutic Gastroscopes, and Dual-Channel Gastroscope.By End User;
Hospitals & Clinics, Diagnostic Labs, Ambulatory Surgical Centers, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Gastroscopes Market (USD Million), 2021 - 2031
In the year 2024, the Global Gastroscopes Market was valued at USD 3,585.88 million. The size of this market is expected to increase to USD 5,463.46 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.
The global gastroscopes market encompasses a range of endoscopic devices used for visualizing and examining the gastrointestinal (GI) tract, particularly the esophagus, stomach, and duodenum. Gastroscopes play a crucial role in the diagnosis, monitoring, and treatment of various GI disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, gastrointestinal bleeding, and cancer. As essential tools in gastroenterology practice, gastroscopes enable healthcare professionals to perform minimally invasive procedures such as upper GI endoscopy, biopsy sampling, and therapeutic interventions, facilitating early detection and management of GI conditions.
Technological advancements drive innovation and evolution in the global gastroscopes market, enhancing device capabilities, imaging quality, and procedural efficiency. Modern gastroscopes incorporate high-definition imaging systems, flexible insertion shafts, and advanced optics, allowing for detailed visualization of mucosal surfaces and accurate tissue characterization. Additionally, innovations such as narrow-band imaging (NBI), autofluorescence imaging, and confocal laser endomicroscopy (CLE) enable real-time detection of subtle mucosal changes, aiding in the early diagnosis of precancerous lesions and improving patient outcomes. Furthermore, the integration of therapeutic accessories such as biopsy forceps, hemostatic clips, and tissue ablation devices expands the utility of gastroscopes for both diagnostic and interventional procedures, supporting comprehensive patient care in gastroenterology practice.
Market dynamics in the global gastroscopes market are shaped by factors such as increasing disease prevalence, growing demand for minimally invasive procedures, and expanding healthcare infrastructure worldwide. The rising incidence of GI disorders, fueled by aging populations, changing dietary habits, and lifestyle factors, underscores the need for effective diagnostic and therapeutic solutions in gastroenterology practice. Furthermore, the shift towards outpatient and ambulatory care settings, driven by cost containment efforts and patient preference for less invasive procedures, drives demand for gastroscopes that offer high-quality imaging, ergonomic design, and procedural versatility. Moreover, initiatives to improve access to endoscopic services, enhance physician training, and promote awareness about GI health contribute to market growth and innovation in the global gastroscopes market, ensuring timely diagnosis and treatment for patients with GI conditions.
Global Gastroscopes Market Recent Developments
-
In November 2023, Olympus Corporation launched the EVIS X1, an advanced endoscopy system in the existing product portfolio of the company.
-
In September 2023, Stryker launched, 1788, a minimally invasive surgical camera, offering more vibrant image with balanced lighting.
Segment Analysis
The Global Gastroscopes Market has been segmented by Application, Type, End User, and Geography, application into diagnostic and therapeutic applications. Diagnostic applications involve the use of gastroscopes to examine the upper gastrointestinal tract, helping to detect conditions like gastritis, ulcers, cancers, and esophageal disorders. These procedures are crucial for early detection and accurate diagnosis of gastrointestinal diseases. Therapeutic applications refer to the use of gastroscopes for performing medical interventions, such as tissue biopsies, polyp removal, and treatment of bleeding ulcers. The growing demand for both diagnostic and therapeutic gastroscopes is driven by the increasing prevalence of gastrointestinal diseases and the need for minimally invasive procedures to provide better patient outcomes.
The market is also segmented by type, including flexible gastroscopes and rigid gastroscopes. Flexible gastroscopes are the most commonly used in clinical practice due to their ability to navigate the curves of the gastrointestinal tract, offering more comfort for patients and providing a comprehensive view of the stomach, esophagus, and duodenum. These devices are typically used for both diagnostic and therapeutic purposes. Rigid gastroscopes, while less common, are sometimes used in specific cases that require a more rigid structure for precise visualizations or when a flexible scope is not suitable. The demand for flexible gastroscopes is expected to dominate the market, driven by advancements in technology and their broad application in clinical settings.
The end-user segment includes hospitals, outpatient surgery centers, and diagnostic centers. Hospitals are the largest end users of gastroscopes, as they are equipped to handle complex diagnostic and therapeutic procedures for a wide range of gastrointestinal diseases. Outpatient surgery centers also play a significant role in the gastroscope market, especially for patients requiring less invasive or elective procedures, such as routine endoscopies or minor interventions. Diagnostic centers, which specialize in imaging and diagnostics, contribute to the market by offering gastroscopy procedures for disease detection and follow-up care. Geographically, North America and Europe are major markets due to their well-established healthcare infrastructure and adoption of advanced medical technologies. However, the Asia-Pacific region is growing rapidly, driven by increasing healthcare access, rising incidences of gastrointestinal diseases, and technological advancements in gastroscope devices.
Global Gastroscopes Segment Analysis
In this report, the Global Gastroscopes Market has been segmented by Application, Type, End User, and Geography.
Global Gastroscopes Market, Segmentation by Application
The Global Gastroscopes Market has been segmented by Application into Contraindications, Gastric Ulcer, and Chronic Gastritis.
The Global Gastroscopes Market is segmented by application into contraindications, gastric ulcer, and chronic gastritis. Contraindications refer to conditions where the use of a gastroscope may be restricted or avoided due to patient-specific factors such as severe cardiac or respiratory issues, or in cases of high risk for complications during the procedure. This segment is primarily focused on the decision-making process in clinical settings, where gastroscopy may be deferred or alternative diagnostic methods may be employed for patients with contraindications.
Gastric ulcer is one of the most common applications for gastroscopy, as it allows for direct visualization of the stomach lining to diagnose, assess the severity, and guide treatment decisions. Gastroscopy is crucial in detecting ulcers, determining their cause, and ruling out malignancy or other underlying issues. As gastric ulcers are often linked to conditions like Helicobacter pylori infection or long-term NSAID use, gastroscopy provides a clear view to facilitate targeted therapy. The market for gastroscopes in gastric ulcer diagnosis and management is significant, driven by the widespread occurrence of this condition and the need for timely intervention.
Chronic gastritis, another major application, involves inflammation of the stomach lining, often due to infection, autoimmune disorders, or the prolonged use of certain medications. Gastroscopy allows for the evaluation of the extent of damage to the gastric mucosa, helps identify potential causes, and enables biopsies to rule out other conditions like gastric cancer. As chronic gastritis is a prevalent condition globally, the gastroscope market is experiencing growth due to the increasing demand for diagnostic precision and the ability to manage complications effectively. Geographically, North America leads the market, owing to high healthcare expenditure, advanced diagnostic capabilities, and high rates of gastric disorders, with Europe following closely behind. The Asia-Pacific region is experiencing rapid growth, driven by increasing healthcare access and rising prevalence of gastric conditions.
Global Gastroscopes Market, Segmentation by Type
The Global Gastroscopes Market has been segmented by Type into Standard Gastroscopes, Transnasal Gastroscopes, Therapeutic Gastroscopes, and Dual-Channel Gastroscope.
Standard gastroscopes represent a foundational segment of the gastroscopes market, characterized by their conventional design featuring a rigid insertion tube and optical lens system. These gastroscopes are commonly used for routine upper gastrointestinal (GI) endoscopy procedures, enabling visualization of the esophagus, stomach, and duodenum for diagnostic purposes such as mucosal inspection, biopsy sampling, and lesion detection. Standard gastroscopes provide clear imaging and maneuverability, making them suitable for a wide range of clinical indications and patient populations.
Transnasal gastroscopes constitute an innovative segment of the gastroscopes market, designed for less invasive and more comfortable endoscopic procedures through the nasal passages. These gastroscopes feature a slim, flexible insertion shaft and smaller diameter optics, allowing for transnasal insertion without the need for sedation or throat anesthesia. Transnasal gastroscopes are particularly well-suited for patients with a history of difficult intubation, gastroesophageal reflux disease (GERD), or esophageal strictures, offering a safe and effective alternative to conventional oral endoscopy.
Therapeutic gastroscopes represent a specialized segment of the gastroscopes market, equipped with additional features and accessories for performing interventional procedures in gastroenterology practice. These gastroscopes may include accessories such as biopsy forceps, hemostatic clips, injection needles, and tissue ablation devices, enabling therapeutic interventions such as polypectomy, hemostasis, stent placement, and endoscopic mucosal resection (EMR). Therapeutic gastroscopes play a crucial role in the management of gastrointestinal bleeding, polyp removal, stricture dilation, and palliative care for patients with advanced GI malignancies.
Dual-channel gastroscopes constitute an advanced segment of the gastroscopes market, featuring two separate working channels for simultaneous diagnostic and therapeutic interventions during endoscopic procedures. These gastroscopes enable efficient and versatile performance of complex procedures such as endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and combined diagnostic and therapeutic interventions. Dual-channel gastroscopes offer enhanced procedural flexibility and efficiency, minimizing the need for instrument exchanges and optimizing patient care in gastroenterology practice.
Global Gastroscopes Market, Segmentation by End User
The Global Gastroscopes Market has been segmented by End User into Hospitals & Clinics, Diagnostic Labs, Ambulatory Surgical Centers, and Others.
Standard gastroscopes represent a foundational segment of the gastroscopes market, featuring a rigid insertion tube and optical lens system for visualizing the esophagus, stomach, and duodenum. These gastroscopes are commonly used for diagnostic purposes, including upper GI endoscopy, biopsy sampling, and mucosal inspection for lesions or abnormalities. Standard gastroscopes provide clinicians with a versatile platform for performing a wide range of endoscopic procedures and interventions, supporting comprehensive patient care in hospitals, clinics, and ambulatory surgery centers.
Transnasal gastroscopes constitute an innovative segment of the gastroscopes market, featuring a flexible insertion shaft designed for transnasal access to the upper GI tract. These gastroscopes offer several advantages over traditional oral gastroscopes, including enhanced patient comfort, reduced gag reflex, and improved maneuverability in anatomically challenging cases. Transnasal gastroscopes are particularly well-suited for patients with oropharyngeal pathology, esophageal strictures, or prior upper GI surgery, enabling safe and effective endoscopic examination and intervention without the need for sedation or anesthesia.
Therapeutic gastroscopes represent a specialized segment of the gastroscopes market, equipped with additional channels, accessories, and features for performing interventional procedures in the upper GI tract. These gastroscopes are used for a variety of therapeutic applications, including hemostasis for gastrointestinal bleeding, polypectomy for polyp removal, stent placement for stricture management, and endoscopic mucosal resection (EMR) for lesion excision. Therapeutic gastroscopes enable gastroenterologists to deliver targeted treatments and interventions directly to the site of pathology, improving procedural outcomes and patient satisfaction.
Dual-channel gastroscopes constitute an advanced segment of the gastroscopes market, featuring two separate working channels for simultaneous diagnostic and therapeutic interventions. These gastroscopes offer enhanced procedural efficiency and versatility, allowing clinicians to perform a wide range of diagnostic and therapeutic procedures in a single endoscopic session. Dual-channel gastroscopes are particularly beneficial for complex cases requiring combined diagnostic evaluation and therapeutic intervention, such as the management of gastrointestinal bleeding, strictures, or neoplastic lesions. By segmenting the gastroscopes market by type, stakeholders can identify emerging trends, technological advancements, and market opportunities, guiding strategic decision-making and investment in gastroenterology innovation and research.
Global Gastroscopes Market, Segmentation by Geography
In this report, the Global Gastroscopes Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Gastroscopes Market Share (%), by Geographical Region, 2024
North America, comprising the United States and Canada, represents a significant market for gastroscopes, driven by factors such as high disease burden, advanced healthcare systems, and robust research and development infrastructure. The region benefits from widespread adoption of gastroscopy for screening, diagnosis, and treatment of upper gastrointestinal disorders, supported by well-established reimbursement policies and clinical guidelines. Increasing prevalence of risk factors such as obesity, gastroesophageal reflux disease (GERD), and Helicobacter pylori infection, coupled with rising demand for minimally invasive endoscopic procedures, contributes to market growth in North America. Furthermore, strategic collaborations between industry stakeholders, academic institutions, and regulatory agencies foster innovation and accelerate the development of next-generation gastroscopy technologies, ensuring timely diagnosis and management of GI conditions.
Europe represents another key market for gastroscopes, comprising countries such as the United Kingdom, Germany, France, and Italy. The region boasts a strong tradition of gastroenterology practice, supported by comprehensive healthcare systems, standardized diagnostic protocols, and quality assurance measures. Increasing disease awareness, rising incidence of gastrointestinal disorders, and expanding indications for gastroscopy drive market growth in Europe. Moreover, initiatives to improve access to endoscopic services, enhance physician training, and promote patient education contribute to market expansion and innovation, ensuring equitable access to high-quality gastroenterology care across diverse socioeconomic and cultural contexts in Europe.
The Asia Pacific region presents significant growth opportunities for the gastroscopes market, encompassing countries such as China, Japan, India, and Australia. Rapid urbanization, changing dietary habits, and aging populations contribute to the rising burden of upper gastrointestinal disorders in Asia Pacific. However, challenges such as limited healthcare infrastructure, disparities in access to specialized care, and variations in disease awareness and treatment practices may impede market growth in certain regions. Nonetheless, increasing investments in healthcare infrastructure, efforts to raise disease awareness, and collaborations between international and local stakeholders drive progress in gastroscopy practice and technology adoption, ensuring timely diagnosis and treatment for patients with upper GI conditions throughout Asia Pacific.
The Middle East and Africa region represents an emerging market for gastroscopes, comprising countries in the Gulf Cooperation Council (GCC) countries, South Africa, and others. While the prevalence of upper gastrointestinal disorders in this region may be lower compared to other parts of the world, increasing adoption of Western dietary patterns, rising prevalence of chronic diseases, and improving access to healthcare services contribute to market growth in the Middle East and Africa. Moreover, initiatives to strengthen healthcare infrastructure, promote disease awareness, and enhance physician training drive market expansion and innovation, ensuring timely access to gastroenterology care and improving patient outcomes across the region.
Latin America, including countries such as Brazil, Mexico, and Argentina, presents another emerging market for gastroscopes. Increasing urbanization, changing lifestyles, and rising prevalence of gastrointestinal disorders contribute to the growing burden of upper GI conditions in Latin America. Efforts to strengthen healthcare infrastructure, promote disease awareness, and improve access to endoscopic services drive market growth and innovation in the region. Additionally, collaborations between public and private sectors, along with initiatives to harmonize regulatory frameworks and improve healthcare delivery, foster advancements in gastroscopy practice and technology adoption, ensuring timely diagnosis and treatment for patients with upper GI conditions throughout Latin America.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Gastroscopes Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Prevalence of Gastrointestinal Disorders
- Rising Demand for Minimally Invasive Procedures
- Growing Adoption of Screening and Diagnostic Endoscopy
-
Expanding Aging Population - The expanding aging population presents a significant driver for the global gastroscopes market. As people age, they become more susceptible to various gastrointestinal conditions and diseases, such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastrointestinal cancers. This demographic trend fuels the demand for gastroscopic procedures for both diagnostic and therapeutic purposes. Gastroscopes play a crucial role in the early detection, diagnosis, and treatment of gastrointestinal disorders among the elderly population, enabling healthcare providers to intervene promptly and improve patient outcomes.
The aging population is often associated with an increased prevalence of chronic medical conditions and comorbidities, which may necessitate regular monitoring and surveillance of gastrointestinal health. Gastroscopes offer a minimally invasive and highly effective means of evaluating the upper gastrointestinal tract, allowing healthcare providers to assess mucosal abnormalities, detect early signs of disease progression, and guide appropriate interventions. Thus, the expanding aging population contributes to the growing demand for gastroscopic procedures as an essential component of comprehensive geriatric care.
The aging population represents a demographic segment with unique healthcare needs and preferences, driving innovation and advancements in gastroscopy technology. Manufacturers are increasingly focusing on developing patient-friendly gastroscopes that are more comfortable, less invasive, and easier to use, catering to the specific requirements of older adults. Additionally, healthcare providers are implementing geriatric-friendly protocols and practices to optimize the safety, efficacy, and patient experience of gastroscopic procedures for elderly individuals. By addressing the distinct needs of the aging population, stakeholders in the gastroscopes market can capitalize on this demographic trend and enhance the accessibility and effectiveness of gastrointestinal care for older adults.
Restraints
- Limited Access to Healthcare Facilities
- Concerns Regarding Infection Control and Sterilization
- Stringent Regulatory Requirements
-
Competition from Alternative Diagnostic Modalities - Competition from alternative diagnostic modalities poses a significant challenge to the global gastroscopes market. While gastroscopy remains a gold standard for diagnosing and treating gastrointestinal disorders, other non-invasive or less invasive diagnostic techniques, such as imaging modalities (e.g., MRI, CT scan), blood tests, and stool tests, are gaining popularity. These alternative modalities offer advantages such as reduced patient discomfort, lower cost, and accessibility, particularly in regions with limited healthcare infrastructure or resources.
Patient preferences and concerns about the invasiveness and potential risks of gastroscopic procedures may drive demand for alternative diagnostic modalities. Some individuals may prefer non-invasive or less invasive approaches to evaluate gastrointestinal health, particularly for routine screening or surveillance purposes. Moreover, healthcare providers may opt for alternative modalities based on factors such as patient comorbidities, procedural risks, and resource availability, further impacting the utilization of gastroscopes in clinical practice.
In response to competition from alternative diagnostic modalities, stakeholders in the gastroscopes market must emphasize the unique advantages and clinical utility of gastroscopy, such as its ability to provide direct visualization, obtain tissue samples for biopsy, and perform therapeutic interventions. Additionally, ongoing innovation and advancements in gastroscopy technology, such as the development of high-definition imaging systems, flexible endoscopes, and minimally invasive techniques, can help differentiate gastroscopy from alternative modalities and maintain its relevance as a valuable diagnostic and therapeutic tool in gastroenterology practice.
Opportunities
- Expansion into Emerging Markets
- Integration of Artificial Intelligence in Endoscopy
- Collaboration with Healthcare Providers for Training and Education
-
Focus on Telemedicine and Remote Endoscopy Services - The increasing focus on telemedicine and remote endoscopy services represents a notable opportunity for the global gastroscopes market. Telemedicine allows healthcare providers to conduct virtual consultations, assessments, and follow-ups with patients remotely, leveraging technology to overcome geographical barriers and improve access to healthcare services. Remote endoscopy services extend this concept to gastrointestinal care, enabling patients to undergo gastroscopic procedures in a convenient and efficient manner without the need for in-person visits to healthcare facilities.
Telemedicine and remote endoscopy services offer several advantages for both patients and healthcare providers. Patients can benefit from the convenience of accessing gastroenterology expertise from the comfort of their homes, reducing travel time, expenses, and logistical challenges associated with in-person appointments. Moreover, telemedicine enables healthcare providers to reach underserved populations, including rural communities and regions with limited access to specialized medical care, thereby improving healthcare equity and patient outcomes.
As telemedicine and remote endoscopy services continue to evolve, stakeholders in the gastroscopes market can capitalize on this trend by investing in technology, infrastructure, and training to support virtual gastroenterology consultations and remote endoscopic procedures. This may involve developing specialized telemedicine platforms tailored to the needs of gastroenterologists and patients, implementing secure and compliant communication channels for transmitting patient data and images, and integrating remote monitoring and telepresence capabilities into endoscopic systems. By embracing telemedicine and remote endoscopy services, stakeholders can expand access to gastroenterology care, improve patient satisfaction, and drive growth in the global gastroscopes market.
Competitive Landscape Analysis
Key players in Global Gastroscopes Market include:
- Olympus Corporation
- Boston Scientific Corporation
- Fujifilm Holdings Corporation
- Pentax Medical
- Perkin Elmer
- KARL STORZ GmbH & Co. KG
- SonoScape Medical Corp
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
-
Market Snapshot, By Application
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Region
-
- Global Gastroscopes Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence of Gastrointestinal Disorders
- Rising Demand for Minimally Invasive Procedures
- Growing Adoption of Screening and Diagnostic Endoscopy
- Expanding Aging Population
- Restraints
- Limited Access to Healthcare Facilities
- Concerns Regarding Infection Control and Sterilization
- Stringent Regulatory Requirements
- Competition from Alternative Diagnostic Modalities
- Opportunities
- Expansion into Emerging Markets
- Integration of Artificial Intelligence in Endoscopy
- Collaboration with Healthcare Providers for Training and Education
- Focus on Telemedicine and Remote Endoscopy Services
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Gastroscopes Market, By Application, 2021 - 2031 (USD Million)
-
Contraindications
-
Gastric Ulcer
-
Chronic Gastritis
-
- Global Gastroscopes Market, By Type, 2021 - 2031 (USD Million)
- Standard Gastroscopes
- Transnasal Gastroscopes
- Therapeutic Gastroscopes
- Dual-Channel Gastroscope
- Global Gastroscopes Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Diagnostic Labs
- Ambulatory Surgical Centers
- Others
- Global Gastroscopes Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Gastroscopes Market, By Application, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Olympus Corporation
- Boston Scientific Corporation
- Fujifilm Holdings Corporation
- Pentax Medical
- Perkin Elmer
- KARL STORZ GmbH & Co. KG
- SonoScape Medical Corp
- Company Profiles
- Analyst Views
- Future Outlook of the Market